↓ Skip to main content

American Association for Cancer Research

Article Metrics

CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Pre-Established Immunity

Overview of attention for article published in Blood Cancer Discovery, January 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#23 of 112)
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
59 tweeters
Title
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Pre-Established Immunity
Published in
Blood Cancer Discovery, January 2022
DOI 10.1158/2643-3230.bcd-21-0222
Pubmed ID
Authors

Tanaya Shree, Vishnu Shankar, Julian JK Lohmeyer, Debra K. Czerwinski, Joseph G Schroers-Martin, Gladys M Rodriguez, Sara Beygi, Alyssa M Kanegai, Karen S Corbelli, Etelka Gabriel, David M. Kurtz, Michael S. Khodadoust, Neel K. Gupta, Lauren S. Maeda, Ranjana H. Advani, Ash A Alizadeh, Ronald Levy

Twitter Demographics

The data shown below were collected from the profiles of 59 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2022.
All research outputs
#760,345
of 20,114,356 outputs
Outputs from Blood Cancer Discovery
#23
of 112 outputs
Outputs of similar age
#16,962
of 310,448 outputs
Outputs of similar age from Blood Cancer Discovery
#4
of 8 outputs
Altmetric has tracked 20,114,356 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 112 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.3. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,448 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.